000			01890cam a2200265ua 4500
008			140604n nyu |||gr||||Z||||||eng
020			_a9781612093949(hbk)
082			_a615.19 _bMAN
245			_aPharmaceutical industry : _binnovation and developments / _cDavid A. Mancuso and Isobel M. Grenada, editors.
260			_aHauppauge, N.Y. : _bNova Science, _c2011..
300			_aix, 182 p. : _c26 cm..
490			_aBusiness issues, competition and entrpreeurship
504			_aIncludes bibliographical references index.
505			_aAuthorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA`s authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO.
650			_aDrug development.
650			_aPharmaceutical industry.
650			_aDrugs _xLaw and legislation.
650	1	2	_aDrug Industry _xeconomics.
650	1	2	_aDrug Industry _xlegislation & jurisprudence.
650	2	2	_aDrug Discovery _xeconomics.
650	2	2	_aDrugs, Generic _xeconomics.
700			_aMancuso, David A.
700			_aGrenada, Isobel M.
942			_cBK
999			_c23166 _d23166